Anti-CD277 (108.5)

Anti-CD277 [108.5], Recombinant, IgG1 kappa, Human
SKU
ABAAb03874-10.3-BT
Packaging Unit
1 mg
Manufacturer
Absolute Antibody

Availability: loading...
Price is loading...
CloneID: 108.5

Heavy Chain modification: Fc Silent™

Antigen Long Description: The original antibody was generated by immunizing BALB/c mice with soluble BT3.1-Ig fusion protein.

Buffer Composition: PBS only.

Chimeric Use Statement: This is a reformatted human IgG1 Fc Silent™ antibody, based on the original human IgG1 format, created for improved compatibility with existing reagents, assays and techniques.

Uniprot Accession No.: O00481

Specificity Statement: This antibody binds human CD277 (BTNA3A1). This protein plays an important role in T-cell activation and in the adaptive immune response. It regulates proliferation of activated T-cells and release of IFNG by activated T-cells. It is expressed on surface of T-cells, natural killer cells, dendritic cells and macrophages (at protein level). It is highly expressed in heart, pancreas and lung and moderately expressed in placenta, liver and muscle.

Application Notes (Clone): This antibody was used as an antagonist antibody to check if BTN3A can specifically enhance Vg9Vd2 TCR-mediated lysis of primary AML blasts using cytotoxic assays. This antibody was reported to significantly and drastically abrogate zoledronate (ZOL)-induced lysis (PMID: 27853633). This antibody can completely abrogate Vγ9Vδ2 T cell mediated lysis of tumors (PMID: 29296524).
More Information
SKU ABAAb03874-10.3-BT
Manufacturer Absolute Antibody
Manufacturer SKU Ab03874-10.3-BT
Package Unit 1 mg
Quantity Unit STK
Reactivity Human
Clonality Recombinant
Application Functional Assay
Isotype IgG1 kappa
Host Human
Product information (PDF) Download
MSDS (PDF) Download